The effect of diuretic treatment ( γ 1 ), after adjusting for other baseline predictors, SBP level and variability, still appears to be highly significant in decreasing CV risk, while the effect of β blocker ( γ 2 ) is weak.
← all excerpts
Modeling biomarker variability in joint analysis of longitudinal and time-to-event data.
1
—
—